ClinicalTrials.gg
RecruitingNCT07808411Updated Sep 8, 2026

Prospective Repeated-Measures Study of Popliteal Vein Diameter During the First 48 Hours After Commercial Air Travel to Bogota for a Plastic Surgery Intervention

An observational study in Physiologic Venous Dilation and Air Travel, sponsored by Research Inc. Recruiting at 1 site in Colombia. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Research Inc · Observational

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This prospective repeated-measures study will evaluate how long popliteal vein dilation persists after international commercial air travel to Bogota. Adult medical travelers will undergo standardized bilateral popliteal vein ultrasound within 24 hours before departure, within 2 hours after arrival, and at 24 and 48 hours after arrival, all before surgery. The primary outcome is change in mean bilateral popliteal vein diameter over time.

Read the detailed description

Eligible international travelers will complete a standardized preflight ultrasound and three postarrival examinations before surgery or intravenous fluid therapy. Each scan will be performed after a fixed resting period using the same popliteal landmark, minimal transducer pressure, and triplicate bilateral measurements. Flight duration, class, seat characteristics, movement, fluid intake, compression stocking use, and venous risk factors will be recorded. Mixed-effects analysis will estimate the postflight diameter and cross-sectional-area trajectory and the proportion returning to within 10% of baseline by 48 hours.

02

Conditions studied

  • Physiologic Venous Dilation
  • Air Travel

Keywords

  • Popliteal Vein
  • Air Travel
  • Medical Tourism
  • Venous Diameter
  • Duplex Ultrasound
  • Long-Haul Flight
03

In context

Lead sponsor

Research Inc is the lead sponsor of 24 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult international medical travelers completing a commercial flight of at least 4 hours to Bogota and undergoing all ultrasound measurements before surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 65 years.
  • International commercial flight to Bogota with total airborne time of at least 4 hours.
  • Preflight baseline ultrasound obtained within 24 hours before departure using the standardized protocol.
  • Arrival ultrasound completed within 2 hours after reaching the study site and before surgery or intravenous fluid therapy.
  • Availability for 24-hour and 48-hour examinations.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Known current deep venous thrombosis or pulmonary embolism.
  • Therapeutic anticoagulation at enrollment.
  • Major lower-extremity venous surgery, active leg infection, or condition preventing popliteal ultrasound.
  • Surgery, prolonged immobilization, or substantial intravenous fluid administration before completion of the 48-hour measurement.
  • Pregnancy.
  • Nondiagnostic baseline examination or inability to reproduce the landmark.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
1 Week
Patient registry
Yes

Groups and cohorts

  • Postflight Repeated-Measures Cohort

    All participants undergo standardized preflight and postarrival bilateral popliteal vein ultrasound without assignment to a travel intervention.

    Other: Commercial Air Travel Exposure · Diagnostic Test: Standardized Bilateral Popliteal Vein Duplex Ultrasound

Interventions

  • OtherCommercial Air Travel Exposure

    Participants complete a commercial flight of at least 4 hours to Bogota. Flight duration, connections, cabin class, seat characteristics, movement, fluid intake, alcohol, sedatives, and compression stocking use will be recorded. Linked arm/group(s): Postflight Repeated-Measures Cohort.

  • Diagnostic testStandardized Bilateral Popliteal Vein Duplex Ultrasound

    After at least 10 minutes of supine rest, the popliteal vein will be imaged at a fixed landmark with minimal probe pressure. Anteroposterior and transverse diameters, cross-sectional area, compressibility, and flow will be recorded in both legs, with three repeated measurements averaged. Linked arm/group(s): Postflight Repeated-Measures Cohort.

06

What researchers measure

Primary outcomes

  1. Change in Mean Bilateral Popliteal Vein Diameter

    At each visit, the mean of three anteroposterior diameter measurements in each leg will be calculated, followed by the mean of both legs. Change from the participant's preflight value will be reported in millimeters and as percent change.

    Time frame: Within 24 hours before departure; within 2 hours after arrival at the study site; 24 +/- 2 hours after arrival; and 48 +/- 2 hours after arrival. 1 week

Secondary outcomes

  1. Return of Popliteal Vein Diameter to Baseline

    Proportion of participants whose mean bilateral diameter is within plus or minus 10% of their preflight value.

    Time frame: 24 +/- 2 hours and 48 +/- 2 hours after arrival. 1 week

  2. Incidental Venous Thrombosis or Abnormal Compressibility

    Number and proportion of participants with a new noncompressible venous segment or other finding requiring diagnostic clinical evaluation. This research protocol is not designed as a definitive thrombosis screening examination unless the final duplex protocol is expanded.

    Time frame: From preflight baseline through 48 hours after arrival. 1week

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Hoyos AE, Ramirez B, Benavides J, Perez Pachon ME, Varela A. Aeromedical Considerations for Patient Safety in Aesthetic Medical Tourism. Aerosp Med Hum Perform. 2024 Oct;95(10):765-770. doi: 10.3357/AMHP.6432.2024. PubMed 39431700 ↗
  • Ramirez B, Aguilar H, Stanford N, Paez Z, Menendez JP, Pachon J, Osorio E, Varela A. Aesthetic Surgical Tourism: Physiological Changes During Flight That May Affect Patient Safety and Outcomes. Plast Reconstr Surg Glob Open. 2026 May 8;14(5):e7568. doi: 10.1097/GOX.0000000000007568. eCollection 2026 May. PubMed 42110381 ↗

Individual participant data

Plan to share: No — not contempled in the patient informed consent

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2024 to primary completion in Sep 2026, 31 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2026
First posted
Sep 8, 2026
StartActual
Jan 12, 2024
Primary completionActual
Sep 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07808411
Lead sponsor
Research Inc
Responsible party
Sponsor
First posted
Sep 8, 2026
Start date
Jan 12, 2024
Primary completion
Sep 1, 2026
Completion
Dec 1, 2026 (estimated)
Last update
Sep 8, 2026

Study contacts

Hugo Aguilar, MD, Plastic surgeon
Contact
havplasticacademy@gmail.com
+57 301 6918526
Hugo Aguilar, MD, plastic surgery
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion